1. Home
  2. DAKT vs EVO Comparison

DAKT vs EVO Comparison

Compare DAKT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.54

Market Cap

923.0M

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.86

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
EVO
Founded
1968
1993
Country
United States
Germany
Employees
2702
4553
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.0M
934.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
DAKT
EVO
Price
$19.54
$2.86
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
243.0K
91.4K
Earning Date
03-04-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
N/A
Revenue This Year
$12.06
$1.37
Revenue Next Year
$9.16
$10.05
P/E Ratio
$25.40
N/A
Revenue Growth
6.89
N/A
52 Week Low
$13.05
$2.31
52 Week High
$28.27
$4.80

Technical Indicators

Market Signals
Indicator
DAKT
EVO
Relative Strength Index (RSI) 46.76 46.32
Support Level $18.99 $2.63
Resistance Level $20.40 $3.78
Average True Range (ATR) 0.56 0.09
MACD -0.03 -0.04
Stochastic Oscillator 33.50 33.38

Price Performance

Historical Comparison
DAKT
EVO

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: